Literature DB >> 16025335

Cholesterol crystal embolization mimicking vasculitis: success with corticosteroid and cyclophosphamide therapy in two cases.

A E Yücel1, H Kart-Köseoglu, B Demirhan, F N Ozdemir.   

Abstract

Cholesterol crystal embolization is a potential complication of atherosclerosis. Approximately one-third of the patients who develop this problem have a history of vascular surgery, angiography or angioplasty hours to weeks before onset. The skin and the kidneys are most frequently involved, but any organ can be affected. Livedo reticularis of the lower extremities and acrocyanosis (known as "blue toe syndrome") are the most common cutaneous manifestations. Histological examination is the only way to definitively diagnose cholesterol crystal embolization. Recently, it has been proposed that cholesterol embolization is associated with vasculitis, and some authors have labeled this condition a "vasculitis look-alike." There is still no specific treatment for this problem, even in cases that progress to renal failure. However, a few case reports in the literature have noted successful treatment with corticosteroids and cyclophosphamide in patients with deteriorating renal function. In this article, we describe two cases of severe cholesterol crystal embolization accompanied by renal dysfunction) and blue toe syndrome. Both patients benefited from corticosteroid and cyclophosphamide therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16025335     DOI: 10.1007/s00296-005-0012-4

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  25 in total

1.  Livedo reticularis caused by cholesterol embolization may improve with simvastatin.

Authors:  T M Finch; K S Ryatt
Journal:  Br J Dermatol       Date:  2000-12       Impact factor: 9.302

2.  Vasculitis due to cholesterol embolism.

Authors:  Y Sijpkens; R Westendorp; F van Kemenade; S van Duinen; F Breedveld
Journal:  Am J Med       Date:  1997-03       Impact factor: 4.965

3.  [Cholesterol embolism and pseudo-periarteritis nodosa. 3 cases].

Authors:  Y Juillet; A Cukier
Journal:  Nouv Presse Med       Date:  1981-01-24

4.  Cholesterol crystal embolization in the Netherlands.

Authors:  W Moolenaar; C B Lamers
Journal:  Arch Intern Med       Date:  1996-03-25

5.  Treatment of atheroembolization with corticosteroids.

Authors:  S J Mann; T A Sos
Journal:  Am J Hypertens       Date:  2001-08       Impact factor: 2.689

6.  The cutaneous manifestations of cholesterol crystal embolization.

Authors:  V Falanga; M J Fine; W N Kapoor
Journal:  Arch Dermatol       Date:  1986-10

Review 7.  [Multiple cholesterol embolism mimicking periarteritis nodosa].

Authors:  J Cosserat; O Bletry; C Frances; B Wechsler; J C Piette; E Kieffer; G Chomette; P Godeau
Journal:  Presse Med       Date:  1992-03-28       Impact factor: 1.228

8.  The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study.

Authors:  Yoshihiro Fukumoto; Hiroyuki Tsutsui; Miyuki Tsuchihashi; Akihiro Masumoto; Akira Takeshita
Journal:  J Am Coll Cardiol       Date:  2003-07-16       Impact factor: 24.094

Review 9.  Renal cholesterol embolic disease. Case report and review of the literature.

Authors:  W C Lye; J S Cheah; R Sinniah
Journal:  Am J Nephrol       Date:  1993       Impact factor: 3.754

10.  Recovery from hemodialysis therapy in a patient with renal cholesterol crystal embolism.

Authors:  Akihiko Kato; Akiko Ohtsuji; Tatsuhiro Terada; Tetsuo Goto; Hirotaka Fukasawa; Hideo Yasuda; Akashi Togawa; Taiki Fujimoto; Hiroyuki Suzuki; Yoshihide Fujigaki; Tatsuo Yamamoto; Katsuhiko Yonemura; Akira Hishida
Journal:  Nephron       Date:  2002-09       Impact factor: 2.847

View more
  9 in total

1.  Blue toes.

Authors:  Mamatha Rao; Mahmood Al-Jufaili; Prashanth Panduranga; Abdullah Amour Riyami
Journal:  Oman Med J       Date:  2012-05

2.  Cholesterol embolization syndrome following thrombolysis during acute myocardial infarction.

Authors:  D M Konstantinou; Y S Chatzizisis; G Farmakis; I Styliadis; G D Giannoglou
Journal:  Herz       Date:  2011-05-14       Impact factor: 1.443

Review 3.  Acrocyanosis: the Flying Dutchman.

Authors:  Andrew K Kurklinsky; Virginia M Miller; Thom W Rooke
Journal:  Vasc Med       Date:  2011-03-22       Impact factor: 3.239

4.  Cholesterol Embolization Syndrome After Kidney Transplantation: A Case Series and Systematic Review.

Authors:  Marith I Francke; Marian C Clahsen-van Groningen; Thierry P P van den Bosch; Jan U Becker; Dennis A Hesselink
Journal:  Transplant Direct       Date:  2021-06-18

5.  Polyneuropathy associated with cholesterol crystal embolism.

Authors:  Matthias Klein; B Hartmann; H J Groene; T A Rupprecht; C Schmidt; T Pfefferkorn; A Straube
Journal:  Neurocrit Care       Date:  2009-09-23       Impact factor: 3.210

6.  Favorable outcome in atheroembolic renal disease with pulse steroid therapy.

Authors:  A Sharma; R Hada; R K Agrawal; A Baral
Journal:  Indian J Nephrol       Date:  2012-11

7.  Cholesterol Crystal Embolism Induced by Direct Factor Xa Inhibitor: A First Case Report.

Authors:  Hideaki Oka; Taro Kamimura; Yuki Hiramatsu; Kento Fukumitsu; Rei Iwata; Mika Kondo; Yutaro Hirashima; Seishi Aihara; Atsumi Harada; Kazuhiko Tsuruya
Journal:  Intern Med       Date:  2017-09-25       Impact factor: 1.271

Review 8.  Contrast-induced acute kidney injury: A review of practical points.

Authors:  Sercin Ozkok; Abdullah Ozkok
Journal:  World J Nephrol       Date:  2017-05-06

9.  Low-dose oral cyclophosphamide therapy reduces atherosclerosis progression by decreasing inflammatory cells in a murine model of atherosclerosis.

Authors:  Yayoi Sato-Okabayashi; Kikuo Isoda; Beate Heissig; Tomoyasu Kadoguchi; Koji Akita; Kenichi Kitamura; Kazunori Shimada; Koichi Hattori; Hiroyuki Daida
Journal:  Int J Cardiol Heart Vasc       Date:  2020-05-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.